Illia Nechai

Dr. Illia Nechai


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
IMIgor Mokryk
Igor Mokryk
BBBogdan Batsak
Bogdan Batsak
INIllia Nechai
Illia Nechai
ISIhor Stetsyuk
Ihor Stetsyuk
BTBorys Todurov
Borys Todurov

1 January 2024 in Annals of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
IMIgor Mokryk
Igor Mokryk
INIllia Nechai
Illia Nechai
ISIhor Stetsyuk
Ihor Stetsyuk
NMNataliia Malova
Nataliia Malova
VDVitaly Demyanchuk
Vitaly Demyanchuk
BTBorys Todurov
Borys Todurov
Purpose: Aortic valve neocuspidization (AVNeo) is a relatively recent advancement in surgical AV replacement. Data on its performance beyond the short term are limited. We assessed the mid-term outcomes in patients undergoing AVNeo, focusing on feasibility, perioperative details, and its role in AV pathology treatment.Methods: Sixty-five consecutive patients underwent AVNeo between December 2016 and February 2018. Clinical data were prospectively collected and retrospectively analyzed. Tricuspid reconstruction with autologous pericardium was performed in all cases. Echocardiographic follow-up was conducted post-discharge, at 6 and 12 months, and annually thereafter.Results: The mean age was 62.6 ± 18.7 years. AVNeo was feasible in all cases. Concomitant procedures were performed in 43 (66.2%) patients. Mean bypass and cross-clamp times were 119.2 ± 30.3 and 87.1 ± 22.9 minutes, respectively. Postoperative transvalvular hemodynamics was excellent. There was one (1.5%) in-hospital death. Follow-up (mean 66.72 ± 12.77 months) was complete in 58 patients (89.2%). There were no detected valve-related or thromboembolic events. Transvalvular hemodynamic parameters were stable during the observation period: peak pressure gradient at discharge and follow-up was 15.3 ± 4.6 mmHg and 15.01 ± 6.3 mmHg, respectively (ρ = 0.346).Conclusions: AVNeo demonstrated the feasibility and favorable mid-term outcomes. Studies with longer-term observation are warranted to evaluate its durability.

24 September 2024 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
IMIgor Mokryk
Igor Mokryk
INIllia Nechai
Illia Nechai
CSChristoph Schmitz
Christoph Schmitz
ISIhor Stetsyuk
Ihor Stetsyuk
OTOleksandr Talalaiev
Oleksandr Talalaiev
BTBorys Todurov
Borys Todurov
Heart valve diseases are a prevalent cardiovascular pathology worldwide, affecting nearly 2.5% of the population. Degenerative aortic stenosis is the most common form of heart valve disease. The treatment options include surgical or transcatheter procedures. There are two main categories of valve prostheses available: mechanical heart valves constructed from synthetic materials and bioprosthetic heart valves made from natural biomaterials. The choice of valve type depends on various factors, including the underlying medical condition, suitability for anticoagulation, valve durability, and the patient’s age and preferences. Mechanical heart valves have the advantage of long-term durability. However, patients receiving mechanical implants are subjected to lifelong anticoagulation therapy with an increased risk of thromboembolism and bleeding. Natural biomaterials do not require long-term anticoagulation. However, they experience degenerative changes leading to structural valve deterioration that may require reoperation. The purpose of this article is to review the role of natural biological materials used for aortic valve replacement or repair, assess their biomedical and clinical advantages and limitations, and analyze the direction and perspectives of future development.

13 January 2026 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
IMIgor Mokryk
Igor Mokryk
INIllia Nechai
Illia Nechai
ISIhor Stetsiuk
Ihor Stetsiuk
AMAlexandros Mourtarakos
Alexandros Mourtarakos
MTMykhailo Todurov
Mykhailo Todurov
BTBorys Todurov
Borys Todurov

1 January 2023 in Polish Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
IMIgor Mokryk
Igor Mokryk
IAIrina Akhmedova
Irina Akhmedova
FHFatemeh Ghasabeh Hassanzadeh
Fatemeh Ghasabeh Hassanzadeh
INIllia Nechai
Illia Nechai
TKTaalaibek Kudaiberdiev
Taalaibek Kudaiberdiev
BTBorys Todurov
Borys Todurov

3 May 2025 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
IMIgor Mokryk
Igor Mokryk
INIllia Nechai
Illia Nechai
ODOlena Dudko
Olena Dudko
DHDmytro Harbuz
Dmytro Harbuz
ISIhor Stetsyuk
Ihor Stetsyuk
BTBorys Todurov
Borys Todurov